Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

NCT00057798 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: vinorelbine ditartrate
GENETIC: cytogenetic analysis
GENETIC: loss of heterozygosity analysis
GENETIC: microarray analysis
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Roswell Park Cancer Institute